Biomedical + LiquiGlide
LiquiGlide’s frictionless technology aims to improve patient outcomes and experiences in medical devices, drug processing and delivery, and numerous other biomedical applications.
The U.S. Food and Drug Administration (FDA) has accepted a Device Master Filing (MAF3464) for LiquiGlide’s biomedical division. This registration provides an additional level of quality assurance and makes it easier for our partner companies to integrate our product into their workflows and obtain approval for new medical products that utilize our first-of-its-kind patented technology.
Read more about our Device Master Filing here
If you’re interested in partnering with us, please contact us here